# Visumax Femtolasik Versus Moria M2 Microkeratome in Myopia

> **NCT03193411** · NA · COMPLETED · sponsor: **Dar Al Shifa Hospital** · enrollment: 30 (actual)

## Conditions studied

- Lasik in Myopia

## Interventions

- **DEVICE:** Visumax femtosecond laser
- **DEVICE:** Moria M2 microkeratome (MK)

## Key facts

- **NCT ID:** NCT03193411
- **Lead sponsor:** Dar Al Shifa Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-05-29
- **Final completion:** 2014-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03193411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03193411, "Visumax Femtolasik Versus Moria M2 Microkeratome in Myopia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03193411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*